NASDAQ •
Healthcare •
Diagnostics & Research •
Quote as of 09/03/2026 16:00
Company Profile
IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization49.7 mln
Float1.63 mln
Earnings Date11/13/2026
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-1.91
Caution advised
Relative Strength
9
/ 100
Severely lagging
Debt / Equity
0.24
Very low leverage
Pre-Tax Margin
-4%
Marginally loss-making
ROE
-8.74
Negative
Business Description
Precipio is a Connecticut-based company specializing in cancer diagnostics, offering blood cancer testing services alongside its own line of laboratory tools and genetic testing panels. Its products help medical professionals identify cancer at the cellular and genetic level with greater accuracy. The company also partners with pharmaceutical and biotech firms to support research through biomarker testing and clinical project work.
